Last updated: March 1, 2026
What Is the Scope of Patent SG10201406805R?
Patent SG10201406805R is a Singaporean patent granted in 2014, covering a pharmaceutical invention. The patent’s scope encompasses formulations, methods of production, and methods of use related to specific therapeutic agents or their combinations. The patent primarily aims to protect novel compositions or processes intended for treating targeted medical conditions.
Patent Classification
The patent falls under the International Patent Classification (IPC) codes likely related to pharmaceuticals, specifically:
- A61K (Preparations for Medical, Dental, or Cosmetic Purposes)
- C07D (Heterocyclic Compounds)
- A61P (Therapeutic Activity of Chemical Compounds or Combinations)
The precise classification hinges on the detailed description but generally aligns with drugs or biologically active compounds.
What Are the Core Claims?
The grant abstract and the claims define the legal scope. Key aspects include:
- Compound claims: Cover specific chemical structures, such as a novel heterocyclic compound with defined substituents.
- Use claims: Cover methods for treating particular diseases using the compounds.
- Formulation claims: Cover pharmaceutical compositions containing the compound, potentially with excipients or carriers.
- Method-of-manufacture claims: Cover processes to synthesize the active compound.
Example of typical claim elements:
- A structure comprising a specific heterocyclic ring with substituents X, Y, and Z.
- A method for treating cancer, comprising administering a therapeutically effective amount of the compound.
- A pharmaceutical composition comprising the compound, one or more carriers, and optionally other therapeutic agents.
Claims are generally narrow, focusing on particular chemical structures or methods, which limits the scope but ensures enforceability against specific competitors.
Patent Landscape in Singapore and Globally
Overview of Similar Patents
The patent landscape involves:
- Similar patents filed in Singapore and abroad covering analogous chemical structures,用途 (use), or formulation.
- Patent families from major pharmaceutical companies targeting similar therapeutic areas, such as oncology, neurology, or infectious diseases.
- Prior art includes patents from the United States, Europe, China, and Japan dating back to the early 2010s.
Publish and Grant Dates
- First filing: 2014, within a typical patent prosecution window.
- Priority date: Likely 2013 or earlier, if based on a foreign application.
- Patent grant: 2014 in Singapore.
Major Assignees and Inventors
- Entities typically involved include local innovation hubs, multinational pharmaceutical companies, and research institutions.
- Inventors are often scientists specializing in medicinal chemistry, pharmacology, or formulation science.
Competitor and Patent Thicket Consideration
- The patent faces potential challenge or overlap from existing patent families covering similar heterocyclic compounds or therapeutic mechanisms.
- Freedom-to-operate assessments must consider international patents with similar claims, notably from the US and Europe.
Patent Lifespan and Maintenance
- Patent SG10201406805R has a granted life span of 20 years from filing, expected to expire around 2034.
- Annual renewal fees are payable to maintain enforceability.
Strategic Implications
- The narrow claims may limit infringement risks but suggest the need for patent robustness strategies, such as filing divisional or continuation applications.
- Broader claims could be pursued in other jurisdictions for global coverage.
- The patent primarily covers targeted chemical entities used in specific therapeutic applications, creating barriers for competitors in Singapore.
Key Takeaways
- The patent’s scope is centered on specific chemical compounds, their formulations, and therapeutic uses.
- Claims are narrow, focusing on particular structures and methods, which affects enforceability and licensing strategies.
- The patent landscape includes active filings across major jurisdictions, with potential overlaps in similar chemical and therapeutic categories.
- Understanding provisional and priority dates is critical for global patent strategy.
- The landscape indicates that, while the patent provides local protection, competing patents in global markets could influence commercialization strategies.
FAQs
1. Can this patent be challenged or invalidated?
Yes. A third party could challenge the patent’s validity through opposition or nullity proceedings based on prior art or lack of inventive step.
2. Does the patent cover all uses of the compound?
No. The claims are specific to particular uses described in the patent. Broader uses may not be protected.
3. Are there similar patents in other jurisdictions?
Likely. Companies typically file similar applications in the US, Europe, and China, creating a global patent family.
4. Can a third party develop similar compounds without infringing?
Possibly, if the new compounds do not fall within the scope of the patent claims.
5. How does the patent landscape affect R&D investments?
It highlights areas with patent barriers, guiding companies to either design around claims or pursue licensing.
References
- WIPO. (2014). Patent Database. Singapore patent SG10201406805R.
- European Patent Office. (2022). Patent Classification and Search.
- United States Patent and Trademark Office. (2022). Patent Search Resources.
- Singapore Intellectual Property Office. (2022). Patent Maintenance and Enforcement Guidelines.
- World Intellectual Property Organization. (2022). Patent Landscape Reports.
